Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinol-D is an over-the-counter (OTC) homeopathic nasal spray developed by Sinol USA for the temporary relief of nasal congestion, sinus pressure, and headaches associated with allergies, sinusitis, and the common cold. The primary active ingredient in Sinol-D is Capsicum annuum (capsicum), which contains capsaicin, a potent agonist of the transient receptor potential vanilloid 1 (TRPV1) channel. Upon intranasal administration, capsaicin binds to TRPV1 receptors on sensory nerve fibers in the nasal mucosa, initially stimulating them and subsequently inducing a prolonged refractory period of desensitization. This desensitization reduces nasal hyperreactivity, alleviates mucosal inflammation, and decreases the release of neuropeptides like substance P, thereby relieving congestion and sinus pain without causing rebound congestion or habit-forming side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sinol-D.